Fifteen-Month Outcomes of Preservative-Free Latanoprost Cationic Emulsion in Open-Angle Glaucoma and Ocular Hypertension: Phase III Open-Label Extension of a Randomized Trial. [PDF]
Clin OphthalmolStalmans I +5 more
europepmc +1 more source
Switch from BAK-preserved to preservative-free latanoprost decreases anterior chamber flare in POAG patients [PDF]
, 2019 De Bacquer, Dirk +3 more
core +2 more sources
Comparison of Circadian Efficacy of Tafluprost Eye Drops (Taflotan Sine<sup>®</sup>) with Latanoprost Eye Drops (Xalatan<sup>®</sup>) in the Treatment of Open-Angle Glaucoma and Ocular Hypertension. [PDF]
J Clin MedBeck A +7 more
europepmc +1 more source
Study on the safety profile of Latanoprost and Timolol in primary open angle glaucoma
, 2015 Sharadashri Rao, Narayanan Parameswaran
openalex +2 more sources
Topical Latanoprost for Eyelid Vitiligo: Effective Repigmentation in Two Pediatric Cases. [PDF]
J Cosmet DermatolLiu L, Mao C.
europepmc +1 more source
Long-Term Outcome of Endothelial Keratoplasty Among Glaucoma Patients and the Risk of Prostaglandin Analogue (Latanoprost) Use on Graft Rejection. [PDF]
J Clin MedAlkharashi MS, Abusayf MM, Aldofyan MZ.
europepmc +1 more source
Using the Mechanisms of Action Involved in the Pathogenesis of Androgenetic Alopecia to Treat Hair Loss. [PDF]
Int J Mol SciSekhavat H, Bar Yehuda S, Asotra S.
europepmc +1 more source
Switching to preservative-free latanoprost: impact on tolerability and patient satisfaction
, 2017 Daniel Beck +3 more
openalex +2 more sources
The Effect of Rebamipide on Ocular Surface Disorders Induced by Latanoprost and Timolol in Glaucoma Patients [PDF]
, 2015 Naoto Tokuda +6 more
openalex +1 more source
Severe Permanent Visual Decline After Hypotony-Induced Retinal Pigment Epithelial Changes. [PDF]
CureusBenekos K +4 more
europepmc +1 more source